New combo therapy shows promise for Tough-to-Treat bile duct cancer
NCT ID NCT07364305
First seen Jan 26, 2026 · Last updated May 23, 2026 · Updated 16 times
Summary
This study is for people with advanced bile duct cancer (ICC) that cannot be removed by surgery. It tests a treatment that delivers chemotherapy directly to the liver (HAIC) along with drugs that boost the immune system. The goal is to see if this combination can shrink tumors and help patients live longer. About 50 adults will take part in this phase 2 trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Eastern Hepatobiliary Surgery Hospital
RECRUITINGShanghai, Shanghai Municipality, 200438, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.